161 related articles for article (PubMed ID: 22010211)
21. Targeting survival and cell trafficking in multiple myeloma and Waldenstrom macroglobulinemia using pan-class I PI3K inhibitor, buparlisib.
Sahin I; Azab F; Mishima Y; Moschetta M; Tsang B; Glavey SV; Manier S; Zhang Y; Sacco A; Roccaro AM; Azab AK; Ghobrial IM
Am J Hematol; 2014 Nov; 89(11):1030-6. PubMed ID: 25060991
[TBL] [Abstract][Full Text] [Related]
22. Carfilzomib-dependent selective inhibition of the chymotrypsin-like activity of the proteasome leads to antitumor activity in Waldenstrom's Macroglobulinemia.
Sacco A; Aujay M; Morgan B; Azab AK; Maiso P; Liu Y; Zhang Y; Azab F; Ngo HT; Issa GC; Quang P; Roccaro AM; Ghobrial IM
Clin Cancer Res; 2011 Apr; 17(7):1753-64. PubMed ID: 21355079
[TBL] [Abstract][Full Text] [Related]
23. Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
Kuang SQ; Bai H; Fang ZH; Lopez G; Yang H; Tong W; Wang ZZ; Garcia-Manero G
Blood; 2010 Mar; 115(12):2412-9. PubMed ID: 20061560
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol exerts antiproliferative activity and induces apoptosis in Waldenström's macroglobulinemia.
Roccaro AM; Leleu X; Sacco A; Moreau AS; Hatjiharissi E; Jia X; Xu L; Ciccarelli B; Patterson CJ; Ngo HT; Russo D; Vacca A; Dammacco F; Anderson KC; Ghobrial IM; Treon SP
Clin Cancer Res; 2008 Mar; 14(6):1849-58. PubMed ID: 18347188
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Eph receptor and ephrin expression within the human cornea and limbus.
Hogerheyde TA; Stephenson SA; Harkin DG; Bray LJ; Madden PW; Woolf MI; Richardson NA
Exp Eye Res; 2013 Feb; 107():110-20. PubMed ID: 23247085
[TBL] [Abstract][Full Text] [Related]
26. Ephrin-B2 regulates endothelial cell morphology and motility independently of Eph-receptor binding.
Bochenek ML; Dickinson S; Astin JW; Adams RH; Nobes CD
J Cell Sci; 2010 Apr; 123(Pt 8):1235-46. PubMed ID: 20233847
[TBL] [Abstract][Full Text] [Related]
27. Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.
Noren NK; Lu M; Freeman AL; Koolpe M; Pasquale EB
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5583-8. PubMed ID: 15067119
[TBL] [Abstract][Full Text] [Related]
28. SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.
Ngo HT; Leleu X; Lee J; Jia X; Melhem M; Runnels J; Moreau AS; Burwick N; Azab AK; Roccaro A; Azab F; Sacco A; Farag M; Sackstein R; Ghobrial IM
Blood; 2008 Jul; 112(1):150-8. PubMed ID: 18448868
[TBL] [Abstract][Full Text] [Related]
29. EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures.
Salvucci O; Maric D; Economopoulou M; Sakakibara S; Merlin S; Follenzi A; Tosato G
Blood; 2009 Aug; 114(8):1707-16. PubMed ID: 19411631
[TBL] [Abstract][Full Text] [Related]
30. Eph receptor interclass cooperation is required for the regulation of cell proliferation.
Jurek A; Genander M; Kundu P; Catchpole T; He X; Strååt K; Sabelström H; Xu NJ; Pettersson S; Henkemeyer M; Frisén J
Exp Cell Res; 2016 Oct; 348(1):10-22. PubMed ID: 27565439
[TBL] [Abstract][Full Text] [Related]
31. Cell type-specific localization of Ephs pairing with ephrin-B2 in the rat postnatal pituitary gland.
Yoshida S; Kato T; Kanno N; Nishimura N; Nishihara H; Horiguchi K; Kato Y
Cell Tissue Res; 2017 Oct; 370(1):99-112. PubMed ID: 28660300
[TBL] [Abstract][Full Text] [Related]
32. EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.
Sikkema AH; den Dunnen WF; Hulleman E; van Vuurden DG; Garcia-Manero G; Yang H; Scherpen FJ; Kampen KR; Hoving EW; Kamps WA; Diks SH; Peppelenbosch MP; de Bont ES
Neuro Oncol; 2012 Sep; 14(9):1125-35. PubMed ID: 22723427
[TBL] [Abstract][Full Text] [Related]
33. Evidence for a dual function of EphB4 as tumor promoter and suppressor regulated by the absence or presence of the ephrin-B2 ligand.
Rutkowski R; Mertens-Walker I; Lisle JE; Herington AC; Stephenson SA
Int J Cancer; 2012 Sep; 131(5):E614-24. PubMed ID: 22161689
[TBL] [Abstract][Full Text] [Related]
34. Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly.
Foo SS; Turner CJ; Adams S; Compagni A; Aubyn D; Kogata N; Lindblom P; Shani M; Zicha D; Adams RH
Cell; 2006 Jan; 124(1):161-73. PubMed ID: 16413489
[TBL] [Abstract][Full Text] [Related]
35. Regulation of vasculogenesis and angiogenesis by EphB/ephrin-B2 signaling between endothelial cells and surrounding mesenchymal cells.
Oike Y; Ito Y; Hamada K; Zhang XQ; Miyata K; Arai F; Inada T; Araki K; Nakagata N; Takeya M; Kisanuki YY; Yanagisawa M; Gale NW; Suda T
Blood; 2002 Aug; 100(4):1326-33. PubMed ID: 12149214
[TBL] [Abstract][Full Text] [Related]
36. Ephrin-B2 regulates VEGFR2 function in developmental and tumour angiogenesis.
Sawamiphak S; Seidel S; Essmann CL; Wilkinson GA; Pitulescu ME; Acker T; Acker-Palmer A
Nature; 2010 May; 465(7297):487-91. PubMed ID: 20445540
[TBL] [Abstract][Full Text] [Related]
37. Regulation of signaling interactions and receptor endocytosis in growing blood vessels.
Pitulescu ME; Adams RH
Cell Adh Migr; 2014; 8(4):366-77. PubMed ID: 25482636
[TBL] [Abstract][Full Text] [Related]
38. Involvement of endothelial ephrin-B2 in adhesion and transmigration of EphB-receptor-expressing monocytes.
Pfaff D; Héroult M; Riedel M; Reiss Y; Kirmse R; Ludwig T; Korff T; Hecker M; Augustin HG
J Cell Sci; 2008 Nov; 121(Pt 22):3842-50. PubMed ID: 18957513
[TBL] [Abstract][Full Text] [Related]
39. Src tyrosine kinase regulates adhesion and chemotaxis in Waldenstrom macroglobulinemia.
Ngo HT; Azab AK; Farag M; Jia X; Melhem MM; Runnels J; Roccaro AM; Azab F; Sacco A; Leleu X; Anderson KC; Ghobrial IM
Clin Cancer Res; 2009 Oct; 15(19):6035-41. PubMed ID: 19755386
[TBL] [Abstract][Full Text] [Related]
40. Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis.
Wang Y; Nakayama M; Pitulescu ME; Schmidt TS; Bochenek ML; Sakakibara A; Adams S; Davy A; Deutsch U; Lüthi U; Barberis A; Benjamin LE; Mäkinen T; Nobes CD; Adams RH
Nature; 2010 May; 465(7297):483-6. PubMed ID: 20445537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
